The primary objective was to detect suited analytical targets by analyzing human hepatocyte incubation samples with significant-resolution mass spectrometry (HRMS) and to verify the final results in reliable urine specimens and to find out AB-FUBINACA's metabolic balance in human liver microsomes and in contrast hepatocyte and urine benefits with i